AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Sitabite M 100mg/1000mg Tablet SR

Prescription Icon
Prescription Required

Marketer

Corona Remedies Pvt Ltd

Salt Composition

Sitagliptin (100mg) + Metformin (1000mg)

Overview Sitabite M 100mg/1000mg Tablet SR

Diabetac Duo 100mg/1000mg Extended-Release Tablets combine two medications to manage elevated blood glucose in individuals with type 2 diabetes. This dual action helps mitigate serious diabetic complications like nephropathy and retinopathy, potentially lowering the risk of cardiovascular events. Diabetac Duo may be used as monotherapy or in conjunction with other antidiabetic agents. Optimal efficacy is achieved with a balanced diet and regular physical activity. Dosage is individualized based on your health status, glucose levels, and other medications. Consuming the tablets with food minimizes gastrointestinal discomfort. Consistent daily dosing at the same time maximizes benefits; discontinuation should only occur under medical supervision. Adherence to your physician's dietary and exercise plan is crucial for diabetes control, as lifestyle significantly impacts management. Common side effects include diarrhea, nausea, vomiting, dyspepsia, headache, and pharyngitis. Hypoglycemia is a potential adverse effect, particularly when combined with insulin or sulfonylureas; learn to recognize and address its symptoms. This medication isn't universally suitable. Inform your doctor of any pre-existing kidney, liver, or heart conditions, pancreatic issues, or significant alcohol consumption before starting treatment. Pregnant or lactating women require medical consultation prior to use. Interactions with other medications are possible; disclose all medications to your doctor to ensure safety. Alcohol should be limited due to its potential to reduce blood glucose. Your doctor will monitor your renal function and blood glucose levels throughout treatment.

Uses of Sitabite M 100mg/1000mg Tablet SR

Managing type 2 diabetes

Major Benefits of Sitabite M 100mg/1000mg Tablet SR:

Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and timeframe. Ingest the Sitabite M 100mg/1000mg Extended-Release tablet whole; avoid chewing, crushing, or fracturing it. Administer this medication with food.

Common Side effects of Sitabite M 100mg/1000mg Tablet SR:

  • Decreased appetite
  • Vomiting
  • Upper respiratory tract infection
  • Hypoglycemia (low blood glucose level)
  • Abdominal bloating
  • Nausea
  • Diarrhea

How to use Sitabite M 100mg/1000mg Tablet SR:

Administer this medication precisely as your physician directs, adhering to the prescribed dosage and treatment period. Ingest the entire tablet without chewing, crushing, or breaking it. Consume the Sitabite M 100mg/1000mg Sustained-Release tablet with a meal.

How Sitabite M 100mg/1000mg Tablet SR works:

Sitagliptin/metformin 100mg/1000mg extended-release tablets (Sitabite M) combine two distinct agents to manage blood glucose. Sitagliptin enhances insulin production by the pancreas, improves insulin utilization, and decreases hepatic glucose output. Metformin, a biguanide, reduces glucose production in the liver, slows intestinal glucose absorption, and increases insulin sensitivity. This synergistic action leads to superior glycemic control.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining alcohol and Sitabite M 100mg/1000mg SR tablets poses a safety risk.

PregnancyPregnancyCONSULT YOUR DOCTOR

Extended-release Sitabite M 100mg/1000mg tablets might pose pregnancy risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the advantages against possible risks prior to prescription. Seek medical advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

The extended-release Sitabite M 100mg/1000mg tablet is likely unsafe for breastfeeding mothers. Available human data indicates potential transfer to breast milk, posing a possible risk to the infant.

DrivingDrivingCAUTION

Driving may be impaired by excessively low or high blood glucose levels. Refrain from driving if such symptoms arise.

KidneyKidneyCAUTION

Patients with impaired kidney function should use Sitabite M 100mg/1000mg SR tablets cautiously, potentially requiring dosage modification. Consult a physician for guidance. Sitabite M 100mg/1000mg SR tablets are contraindicated in individuals with severe kidney disease. Routine monitoring of renal function is recommended during treatment.

LiverLiverUNSAFE

Use of Sitabite M 100mg/1000mg SR tablets is likely inadvisable for individuals with hepatic impairment and should be avoided. Physician consultation is recommended.

What if you forget to take Sitabite M 100mg/1000mg Tablet SR :

Should you forget a dose of Sitabite M 100mg/1000mg sustained-release tablet, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Sitabite M 100mg/1000mg Tablet SR

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Sitabite M 100mg/1000mg Tablet SR

Sitabite M 100mg/1000mg SR tablets combine sitagliptin and metformin to treat type 2 diabetes in adults. This combination improves blood sugar control when used with diet and exercise. Metformin reduces liver glucose production and enhances insulin sensitivity, while sitagliptin boosts insulin release by inhibiting DPP-4. This medication is not suitable for individuals under 18.
Prolonged use of Sitabite M 100mg/1000mg Tablet SR can lead to vitamin B12 deficiency by hindering its absorption in the stomach. This deficiency may cause anemia, nerve damage (manifesting as tingling, numbness in extremities, weakness, urinary issues, cognitive changes, and ataxia), if left unaddressed. To mitigate this risk, annual supplementation with vitamin B12 is recommended by some researchers.
Sitabite M 100mg/1000mg SR tablets may cause common side effects including hypoglycemia, altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory infections. Rare but serious side effects such as lactic acidosis are possible. Prolonged use may also result in vitamin B12 deficiency.
Patients with known allergies to Sitabite M 100mg/1000mg Tablet SR components or excipients, or those with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis should not use this medication.
Combining Sitabite M 100mg/1000mg SR tablets with alcohol is unsafe and may raise the risk of lactic acidosis.
Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication safely and ensure it's inaccessible to children, pets, and others.
Sitabite M 100mg/1000mg SR (containing metformin) can cause lactic acidosis, a serious medical emergency characterized by high blood lactic acid levels (also known as MALA – Metformin-associated lactic acidosis). This rare side effect necessitates avoiding its use in patients with kidney disease, the elderly, or those who consume excessive alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these, discontinue Sitabite M and seek immediate medical attention.
Sitabite M 100mg/1000mg SR tablets combine sitagliptin and metformin to manage type 2 diabetes in adults. This medication improves blood sugar control when used with diet and exercise. Metformin reduces liver glucose production and enhances insulin sensitivity, while sitagliptin increases insulin release by inhibiting DPP-4. It's not suitable for individuals under 18.
Sitabite M 100mg/1000mg SR tablets may cause common side effects such as hypoglycemia, altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory infections. Rare but serious side effects include lactic acidosis. Prolonged use can also result in vitamin B12 deficiency.
Patients with allergies to Sitabite M 100mg/1000mg Tablet SR components or excipients, or those with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis should not use this medication.
Combining alcohol and Sitabite M 100mg/1000mg SR tablets is unsafe due to the increased risk of lactic acidosis.
Sitabite M 100mg/1000mg SR can cause lactic acidosis, a serious medical emergency resulting from excessive blood lactic acid (also known as MALA – Metformin-associated lactic acidosis). This rare side effect necessitates avoiding Sitabite M in patients with kidney disease, the elderly, or those who consume significant alcohol. Symptoms include muscle pain/weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these, discontinue Sitabite M and seek immediate medical attention.
Prolonged use of Sitabite M 100mg/1000mg Tablet SR can lead to vitamin B12 deficiency by hindering its absorption. This deficiency, if left untreated, may cause anemia, nerve damage (manifesting as tingling, numbness in extremities, weakness, and balance problems), urinary issues, and cognitive changes. To mitigate this risk, annual supplemental vitamin B12 is recommended by some researchers.
Store this medication in its original, tightly closed container, following the storage instructions on the label or packaging. Discard any unused medication and ensure it's inaccessible to children, pets, and others.
Sitabite M 100mg/1000mg SR tablets combine sitagliptin and metformin to manage type 2 diabetes in adults. This treatment improves blood sugar control when used with diet and exercise. Metformin reduces liver glucose production and enhances insulin sensitivity, while sitagliptin boosts insulin release by inhibiting DPP-4. This combination is unsuitable for individuals under 18.
Sitabite M 100mg/1000mg SR tablets may cause common side effects such as hypoglycemia, altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory infections. Rare but serious side effects include lactic acidosis. Prolonged use can also result in vitamin B12 deficiency.
Patients with known allergies to Sitabite M 100mg/1000mg Tablet SR components or excipients, or those with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis should not use this medication.
Combining alcohol and Sitabite M 100mg/1000mg SR tablets is unsafe due to the increased risk of lactic acidosis.
Sitabite M 100mg/1000mg SR (containing metformin) can cause lactic acidosis, a serious medical emergency characterized by excessive blood lactic acid (also known as MALA – Metformin-Associated Lactic Acidosis). While rare, this risk is heightened in patients with kidney disease, the elderly, or those who consume significant alcohol. Symptoms may include muscle pain/weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If these occur, discontinue Sitabite M and seek immediate medical attention.
Prolonged use of Sitabite M 100mg/1000mg Tablet SR can lead to vitamin B12 deficiency by hindering its absorption. This deficiency may cause anemia, nerve damage (manifested as tingling, numbness in extremities, weakness, and balance problems), and urinary issues, potentially affecting mental clarity. To mitigate these risks, annual supplemental vitamin B12 is recommended by some researchers.
Store this medication in its original, tightly closed container as directed on the label. Discard any unused medication and keep it out of reach of children, pets, and others.
Sitabite M 100mg/1000mg T...
151
MRP 175
13% off